Key statistics
On Friday, Charles River Laboratories International Inc (CRL:NYQ) closed at 168.92, -26.20% below its 52-week high of 228.88, set on Jan 13, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 162.54 |
|---|---|
| High | 171.93 |
| Low | 161.46 |
| Bid | 150.00 |
| Offer | 177.66 |
| Previous close | 164.24 |
| Average volume | 1.69m |
|---|---|
| Shares outstanding | 49.23m |
| Free float | 48.72m |
| P/E (TTM) | -- |
| Market cap | 8.09bn USD |
| EPS (TTM) | -2.96 USD |
Data delayed at least 15 minutes, as of Feb 20 2026 21:00 GMT.
More ▼
- Charles River Laboratories Announces Executive Appointments
- Charles River Laboratories Announces Fourth-Quarter and Full-Year 2025 Results and Provides 2026 Guidance
- Charles River Laboratories Schedules Fourth-Quarter 2025 Earnings and 2026 Guidance Release and Conference Call
- Charles River Enters Manufacturing Collaboration with Gazi University
- Charles River Laboratories Provides Business Updates
- Charles River Laboratories Announces Planned Retirement of James C. Foster and CEO Succession Plan
- Charles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program Cohort
- Charles River Laboratories to Present at Evercore Healthcare Conference
More ▼
